Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2007 3
2008 15
2009 16
2010 7
2011 18
2012 14
2013 8
2014 10
2015 16
2016 13
2017 11
2018 6
2019 6
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

121 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean sheng yong gang (2 results)?
Novel ROR1 inhibitor ARI-1 suppresses the development of non-small cell lung cancer.
Liu X, Pu W, He H, Fan X, Zheng Y, Zhou JK, Ma R, He J, Zheng Y, Wu K, Zhao Y, Yang SY, Wang C, Wei YQ, Wei XW, Peng Y. Liu X, et al. Among authors: yang sy. Cancer Lett. 2019 Aug 28;458:76-85. doi: 10.1016/j.canlet.2019.05.016. Epub 2019 May 21. Cancer Lett. 2019. PMID: 31125641
Inhibition of Stat3 signaling pathway by nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasis.
Ye TH, Yang FF, Zhu YX, Li YL, Lei Q, Song XJ, Xia Y, Xiong Y, Zhang LD, Wang NY, Zhao LF, Gou HF, Xie YM, Yang SY, Yu LT, Yang L, Wei YQ. Ye TH, et al. Among authors: yang sy. Cell Death Dis. 2017 Jan 5;8(1):e2534. doi: 10.1038/cddis.2016.452. Cell Death Dis. 2017. PMID: 28055016 Free PMC article.
Correction: Inhibition of Stat3 signaling pathway by nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasis.
Ye TH, Yang FF, Zhu YX, Li YL, Lei Q, Song XJ, Xia Y, Xiong Y, Zhang LD, Wang NY, Zhao LF, Gou HF, Xie YM, Yang SY, Yu LT, Yang L, Wei YQ. Ye TH, et al. Among authors: yang sy. Cell Death Dis. 2019 Sep 26;10(10):722. doi: 10.1038/s41419-019-1955-9. Cell Death Dis. 2019. PMID: 31558703 Free PMC article.
Clinical Success of Drug Targets Prospectively Predicted by In Silico Study.
Zhu F, Li XX, Yang SY, Chen YZ. Zhu F, et al. Among authors: yang sy. Trends Pharmacol Sci. 2018 Mar;39(3):229-231. doi: 10.1016/j.tips.2017.12.002. Epub 2017 Dec 30. Trends Pharmacol Sci. 2018. PMID: 29295742
(2-Anilino-4-methyl-thia-zol-5-yl)(4-chloro-phen-yl)methanone.
Liu JJ, Zheng RL, Yang SY, Xie YM. Liu JJ, et al. Among authors: yang sy. Acta Crystallogr Sect E Struct Rep Online. 2012 Jan;68(Pt 1):o161. doi: 10.1107/S1600536811053463. Epub 2011 Dec 17. Acta Crystallogr Sect E Struct Rep Online. 2012. PMID: 22259446 Free PMC article.
3-Amino-N-benzyl-6-(4-fluoro-phen-yl)thieno[2,3-b]pyridine-2-carboxamide.
Zhao JN, Yang SY, Yang L. Zhao JN, et al. Among authors: yang sy. Acta Crystallogr Sect E Struct Rep Online. 2012 Jun 1;68(Pt 6):o1823. doi: 10.1107/S160053681202212X. Epub 2012 May 19. Acta Crystallogr Sect E Struct Rep Online. 2012. PMID: 22719595 Free PMC article.
4-(4-Nitro-phen-yl)morpholine.
Wang LJ, Li WW, Yang SY, Yang L. Wang LJ, et al. Among authors: yang sy. Acta Crystallogr Sect E Struct Rep Online. 2012 Apr 1;68(Pt 4):o1235. doi: 10.1107/S1600536812012172. Epub 2012 Mar 31. Acta Crystallogr Sect E Struct Rep Online. 2012. PMID: 22606168 Free PMC article.
Structural insights into drug development strategy targeting EGFR T790M/C797S.
Zhu SJ, Zhao P, Yang J, Ma R, Yan XE, Yang SY, Yang JW, Yun CH. Zhu SJ, et al. Among authors: yang sy. Oncotarget. 2018 Jan 10;9(17):13652-13665. doi: 10.18632/oncotarget.24113. eCollection 2018 Mar 2. Oncotarget. 2018. PMID: 29568384 Free PMC article.
PRMT1 promotes neuroblastoma cell survival through ATF5.
Hua ZY, Hansen JN, He M, Dai SK, Choi Y, Fulton MD, Lloyd SM, Szemes M, Sen J, Ding HF, Angelastro JM, Fei X, Li HP, Wu CR, Yang SY, Malik K, Bao X, George Zheng Y, Liu CM, Schor NF, Li ZJ, Li XG. Hua ZY, et al. Among authors: yang sy. Oncogenesis. 2020 May 15;9(5):50. doi: 10.1038/s41389-020-0237-9. Oncogenesis. 2020. PMID: 32415090 Free PMC article.
121 results
Jump to page
Feedback